New Key Statistics Module, Z-Score and F-Score
SHSE:603079 Key Ratios
Market Cap ¥ M | 1,773.52 |
Enterprise Value ¥ M | 1,761.34 |
P/E(ttm) | -- |
PE Ratio without NRI | 62.79 |
Forward PE Ratio | -- |
Price/Book | 1.42 |
Price/Sales | 2.20 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.36 |
Revenue (TTM) ¥ M | 748.00 |
EPS (TTM) ¥ | -0.18 |
Beneish M-Score | -2.95 |
10-y EBITDA Growth Rate % | -5.00 |
5-y EBITDA Growth Rate % | -19.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -93.36 |
EV-to-EBITDA | -93.36 |
PEG | -- |
Shares Outstanding M | 171.19 |
Net Margin (%) | -4.17 |
Operating Margin % | 2.19 |
Pre-tax Margin (%) | -2.83 |
Quick Ratio | 1.90 |
Current Ratio | 2.96 |
ROA % (ttm) | -1.83 |
ROE % (ttm) | -2.45 |
ROIC % (ttm) | 1.82 |
Dividend Yield % | 0.58 |
Altman Z-Score | 3.51 |
SHSE:603079 Number of Guru Trades
SHSE:603079 Volume of Guru Trades
Gurus Latest Trades with SHSE:603079
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603079 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Shengda Bio-Pharm Co Ltd Insider Transactions
No Available Data